https://www.selleckchem.com/pr....oducts/gsk2256098.ht
8 years. Day 100 transplant-related mortality (TRM) was 0%. Two patients died at later time points, 1 from intracranial hemorrhage/disseminated fungal infection in the setting of graft failure and 1 from infection/GVHD. The estimated probabilities of grades II-IV and III-IV acute GVHD at day 100 and 2-year NIH-consensus chronic GVHD were 78%, 26% and 42%, respectively. With a median follow-up of 2.5 years, the 2-year overall and event-free rates of survival were 91% and 78%, respectively. These results are encouraging and demonstrate
Like
Comment
Share
